tags

Cosmetics
EU
China and Global Cosmetics Regulatory Updates-Vol.33 (November 2025)

This article compiles and summarizes the latest developments in cosmetics regulations in China and globally as of November 2025, covering industry news, newly issued regulations, latest standards updates, relevant policy adjustments, and regulatory requirements. It aims to assist enterprises in ensuring compliance and keeping up with global cosmetics regulatory trends.

Regulatory Trends and Compliance Strategies for PFAS in Cosmetics

Per- and polyfluoroalkyl substances (PFAS) are increasingly becoming a focal point of global concern due to their potential long-term impacts on the environment and human health. As a class of synthetic chemicals characterized by high stability and widespread applications, PFAS are facing increasingly stringent regulatory scrutiny in the cosmetics sector. This article explores the physicochemical properties and potential health risks of PFAS, and systematically reviews the evolving global regulatory landscape related to their use in cosmetics. It aims to help cosmetic enterprises gain a comprehensive understanding of regulatory requirements, mitigate compliance risks, enhance product safety, and strengthen competitiveness in international markets.

SCCS Issued Scientific Advice on the safety of Diethylamino Hydroxybenzoyl Hexyl Benzoate (DHHB)

On June 30, 2025, the Scientific Committee on Consumer Safety (SCCS) of the European Union issued scientific opinion(SCCS/1678/25) on Diethylamino Hydroxybenzoyl Hexyl Benzoate (DHHB) (CAS/EC No. 302776-68-7/443-860-6). Previously, on February 17, 2025, the SCCS published the scientific opinion on this substance which was open for comments. The scientific advice released this time is consistent with the assessment conclusions proposed during the comment phase and further confirms the maximum safe level and recommends the target maximal level of DnHexP as an impurity in DHHB.

Major Reform to EU REACH Regulation Impacts the Cosmetics Industry

On April 3, 2025, at the CARACAL-54 meeting of the joint advisory body REACH-CLP, the European Commission officially released the final proposal for the reform of the REACH Regulation. The European Chemical Industry Council (Cefic) pointed out that the digital transformation is expected to increase costs for SMEs by 40%, and that the 10-year review cycle and complex mixed assessment models may slow down the development of innovative pharmaceuticals.